Skip to main navigation Skip to search Skip to main content

Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study) : a placebo-controlled randomised phase 4 trial

  • the SIMCOMBIN study investigators

    Research output: Contribution to journalArticleScientificpeer-review

    105 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)691-701
    JournalThe Lancet Neurology
    Volume10
    Issue number8
    DOIs
    Publication statusPublished - 2011
    Publication typeA1 Journal article-refereed

    Cite this